| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 22:27:34 UTC |
|---|
| Updated at | 2022-04-27 22:27:34 UTC |
|---|
| NP-MRD ID | NP0051006 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | alpha-Narcotine |
|---|
| Description | (-)-Alpha-Narcotine, also known as capval or noscapina, belongs to the class of organic compounds known as phthalide isoquinolines. These are organic compounds with a structure characterized by an isoquinoline moiety linked to phthalide (-)-alpha-Narcotine is a very strong basic compound (based on its pKa) (-)-alpha-Narcotine is a bitter tasting compound. Outside of the human body, (-)-alpha-Narcotine has been detected, but not quantified in, opium poppies. alpha-Narcotine is found in Apis cerana, Citrus sinensis , Corydalis heterocarpa, Corydalis solida, Papaver commutatum, Papaver pseudo-orientale, Papaver rhoeas , Papaver rhopalothece and Papaver somniferum . alpha-Narcotine was first documented in 2012 (PMID: 22079300). This could make (-)-alpha-narcotine a potential biomarker for the consumption of these foods (PMID: 22546556) (PMID: 22653730) (PMID: 22671862) (PMID: 22733149). |
|---|
| Structure | [H][C@@]1(OC(=O)C2=C1C=CC(OC)=C2OC)[C@]1([H])N(C)CCC2=CC3=C(OCO3)C(OC)=C12 InChI=1S/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/t17-,18+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (-)-Narcotine | ChEBI | | alpha-Narcotine | ChEBI | | Noscapina | ChEBI | | Noscapine | ChEBI | | Noscapinum | ChEBI | | a-Narcotine | Generator | | Α-narcotine | Generator | | (-)-a-Narcotine | Generator | | (-)-Α-narcotine | Generator | | Capval | HMDB | | Coscopin | HMDB | | L-alpha-Narcotine | HMDB | | Longatin | HMDB | | Lyobex | HMDB | | Methoxyhydrastine | HMDB | | Narcompren | HMDB | | Narcosine | HMDB | | Narcotin | HMDB | | Narcotussin | HMDB | | Narkotin | HMDB | | Nectadon | HMDB | | Nicolane | HMDB | | Nipaxon | HMDB | | Noscapal | HMDB | | Noscapalin | HMDB | | Noscapin | HMDB | | Noscapine (JP15/usp/inn) | HMDB | | Noscopine | HMDB | | O-Methylnarcotoline | HMDB | | Opian | HMDB | | Opianin | HMDB | | Opianine | HMDB | | Terbenol | HMDB | | Tusscapine | HMDB | | Vadebex | HMDB | | Hydrogen embonate, noscapine | MeSH | | Noscapine hydrogen embonate | MeSH | | Hydrochloride, noscapine | MeSH | | Prikkelhoest, librochin | MeSH | | Noscapine hydrochloride | MeSH | | Librochin prikkelhoest | MeSH | | Embonate, noscapine hydrogen | MeSH | | Narcotine | MeSH | | Tuscalman | MeSH | | Capval tropfen | MeSH | | Tropfen, capval | MeSH | | Noscapect | MeSH | | (-)-alpha-Narcotine | ChEBI |
|
|---|
| Chemical Formula | C22H23NO7 |
|---|
| Average Mass | 413.4205 Da |
|---|
| Monoisotopic Mass | 413.14745 Da |
|---|
| IUPAC Name | (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-one |
|---|
| Traditional Name | noscapine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]1(OC(=O)C2=C1C=CC(OC)=C2OC)[C@]1([H])N(C)CCC2=CC3=C(OCO3)C(OC)=C12 |
|---|
| InChI Identifier | InChI=1S/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/t17-,18+/m1/s1 |
|---|
| InChI Key | AKNNEGZIBPJZJG-MSOLQXFVSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phthalide isoquinolines. These are organic compounds with a structure characterized by an isoquinoline moiety linked to phthalide. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Phthalide isoquinolines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Phthalide isoquinolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phthalide isoquinoline
- Isobenzofuranone
- Benzofuranone
- Tetrahydroisoquinoline
- Phthalide
- Benzodioxole
- Isocoumaran
- Anisole
- Alkyl aryl ether
- Aralkylamine
- Benzenoid
- Amino acid or derivatives
- Carboxylic acid ester
- Lactone
- Tertiary aliphatic amine
- Tertiary amine
- Acetal
- Carboxylic acid derivative
- Oxacycle
- Ether
- Azacycle
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Amine
- Organic oxygen compound
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Navaee A, Salimi A, Teymourian H: Graphene nanosheets modified glassy carbon electrode for simultaneous detection of heroine, morphine and noscapine. Biosens Bioelectron. 2012 Jan 15;31(1):205-11. doi: 10.1016/j.bios.2011.10.018. Epub 2011 Oct 19. [PubMed:22079300 ]
- Yang ZR, Liu M, Peng XL, Lei XF, Zhang JX, Dong WG: Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochem Biophys Res Commun. 2012 May 11;421(3):627-33. doi: 10.1016/j.bbrc.2012.04.079. Epub 2012 Apr 22. [PubMed:22546556 ]
- Winzer T, Gazda V, He Z, Kaminski F, Kern M, Larson TR, Li Y, Meade F, Teodor R, Vaistij FE, Walker C, Bowser TA, Graham IA: A Papaver somniferum 10-gene cluster for synthesis of the anticancer alkaloid noscapine. Science. 2012 Jun 29;336(6089):1704-8. doi: 10.1126/science.1220757. Epub 2012 May 31. [PubMed:22653730 ]
- Fang ZZ, Krausz KW, Li F, Cheng J, Tanaka N, Gonzalez FJ: Metabolic map and bioactivation of the anti-tumour drug noscapine. Br J Pharmacol. 2012 Nov;167(6):1271-86. doi: 10.1111/j.1476-5381.2012.02067.x. [PubMed:22671862 ]
- Gajewski MM, Alisaraie L, Tuszynski JA: Peloruside, laulimalide, and noscapine interactions with beta-tubulin. Pharm Res. 2012 Nov;29(11):2985-93. doi: 10.1007/s11095-012-0809-2. Epub 2012 Jun 26. [PubMed:22733149 ]
|
|---|